Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

25.83 +0.06 (+0.23%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
Three Stocks That Are Set Up For A Great Second Quarter Of 2024
Culling the weak, but holding the strong. 
Via Talk Markets
Blue-Chip Bulldozers: 7 Stock Giants to Plow Through a Wall of Worries
With the smart money diversifying their exposure to risk-on names, now’s the time to consider blue-chip stocks to buy. 
Via InvestorPlace
2 Stocks Down 30% and 27% to Buy and Hold
Look beyond these companies' challenges. 
Via The Motley Fool
Jim Cramer Says Chevron Is Doing 'Pretty Well,' Will Give This Pharma Giant 'A Chance'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Core & Main, Inc. (NYSE: CNM) is "right at the heart of this infrastructure bull market I keep talking about because it does waste water. 
Via Benzinga
4 Dividend Aristocrats Trading at a Discount
Near the end of the first quarter, a shift toward more defensive sectors occurred, prompting investors to buy fair-value dividend stocks like MO, T, F, and PFE 
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
Better Recovery Story Buy: Pfizer vs Moderna
Pfizer and Moderna each have slipped about 30% over the past year. 
Via The Motley Fool
Pfizer's Options: A Look at What the Big Money is Thinking
Via Benzinga
Healthcare And Biotech Stocks Review: Q1 2024 Performance
We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months
Over the past 12 months, 10 Large-Cap stocks have underperformed all others. 
Via Talk Markets
Prediction: Pfizer Won't Acquire Viking Therapeutics. Here's Why.
Viking Therapeutics may be the next company to enter the red-hot weight loss space. 
Via The Motley Fool
Groundbreaking Documentary ‘Project Whistleblower’ Pulls Back the Curtain on Corporate Misconduct
Via Press Release Distribution Service
Topics Whistleblower
Exposures Legal
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Spring Cleaning Alert: 7 Dreadful Stocks to Ditch Now
There’s no time like the present to rid your portfolio of underperforming stocks to sell. Avoid these stocks to have a successful 2024. 
Via InvestorPlace
7 Dividend Stocks to Secure Your Financial Freedom by 2026
Explore seven dividend stocks for financial freedom in banking, insurance, construction, pharmaceuticals, and telecommunications. 
Via InvestorPlace
3 Biotech Stocks to Buy on the Dip: March 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. 
Via InvestorPlace
The 2025 Double: 3 Stocks Poised to Deliver 100% Gains in Just 12 Months
Let's review what Wall Street analysts believe are potentially the stocks to double over the next 12 months. 
Via InvestorPlace
3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
Each of these three companies are entering a new era of growth. 
Via The Motley Fool
Adobe Revolutionizes Content Supply Chain With New Generative AI Tools
Adobe introduces GenStudio and Firefly, a suite of AI tools that streamline content creation and management, addressing the challenges of the content supply chain. Strategic partnerships and new... 
Via Benzinga
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Harnessing AI for Drug Discovery: Top 3 Stocks to Watch
As biotech innovators look to AI to smoothen out the drug discovery process, the leaders in the scene could stand to benefit greatly. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever
If you have a Benjamin burning a hole in your pocket, these stocks are a great way to invest it. 
Via The Motley Fool
Buffett’s Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating
Warren Buffett stocks and Berkshire Hathaway's portfolio of companies are hidden investment vehicles hiding in plain sight. 
Via InvestorPlace
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the pharma giants. 
Via The Motley Fool
3 Ultra-High-Yield Dividend Stocks That Could Realistically Double Your Money by 2030
There's no guarantee these stocks can generate 100% returns by 2030. But they have a clear path to make it happen. 
Via The Motley Fool
Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?
What's good for Wood and Ark Invest might not be good for other investors. 
Via The Motley Fool
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
The price could be right for these three biopharma stocks. 
Via The Motley Fool
7 Stocks That Will Make Your Friends Green with Envy
Discover stocks set to dazzle the market with innovative business models and disruptive technologies. Dive in for potential outperformance. 
Via InvestorPlace
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now
These stocks share several things in common. 
Via The Motley Fool
2 High-Yield Dividend Stocks Near 52-Week Lows. Time to Buy the Dips?
After a lousy year of declining prices, these stocks offer yields of 4.7% and 6.1% at recent prices. 
Via The Motley Fool
Will Pfizer Be a Trillion-Dollar Stock by 2035?
A market cap of $1 trillion for Pfizer over the next 11 or so years? Possible, but not probable. 
Via The Motley Fool
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.